MRC1 and colorectal cancer: Among the 334 patients with colorectal cancer, 25 (7.5%) carried a pathogenic MMR gene variant; among the 125 patients with endometrial cancer, 14 (11.2%) carried a pathogenic MMR gene variant (Table 1).